Contaminated IV glutathione recalled as CDC investigates 25+ illnesses
One of the wellness world's favorite IV drips is at the center of a federal safety investigation. Centric Compounding has recalled six lots of injectable glutathione and Myers' cocktail vials — shipped to homes nationwide — over elevated endotoxin levels, after disclosing nine adverse-event reports. The company warns of “reasonable probability” of fevers, hypotension, inflammatory reactions, anaphylactic shock, and death. The CDC now counts 25+ illnesses in at least four states, with at least three hospitalizations.
What went wrong
The common thread: the injections were compounded with dietary-supplement-grade glutathione, which the FDA says must never be used in injectable compounding because of endotoxin contamination risk. The CDC traced one Medisca lot earlier; Centric is the third pharmacy recall after Victory Medical Center Pharmacy (Austin) and Optimal Balance Pharmacy (Houston). All three known hospitalized patients received IV glutathione; one ICU patient was treated for shock and abnormal blood clotting.
What this doesn't mean
This is not an indictment of glutathione itself or of all compounded injectables. Properly compounded pharmaceutical-grade injectables remain a legitimate medical tool. The failure here was a grade mismatch — supplement-grade raw material in a sterile injectable — and the FDA has warned pharmacies to discontinue the practice.
What to ask before any IV drip
If you get IV therapy at a clinic or med-spa, ask where the ingredients are sourced, whether they're pharmaceutical grade, and which compounding pharmacy made them. A reputable clinic answers those questions easily. This story is a reminder that wellness IVs deserve the same scrutiny as any medical product — because they are one.
Where the evidence stands
- Established: The FDA-posted recall (Sept 13) and the CDC's adverse-event investigation (25+ illnesses, four states) are matters of public record.
- Preliminary: The full scope of exposure is still being traced; additional lots or pharmacies may yet be implicated.
- Contested: Nothing about glutathione's legitimate medical uses is in dispute — the issue is manufacturing grade, not the molecule.
- Absent: No evidence that pharmaceutical-grade compounded glutathione carries the same risk.